Last Price
9.35
Today's Change
+7.83 (515.46%)
Day's Change
8.119 - 17.75
Trading Volume
73,319,965
Profile
ATNF
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Lloyd Blair Jordan L.L.B., M.B.A. Mr. Lloyd Blair Jordan L.L.B., M.B.A.
Full Time Employees: 4 4
IPO Date: 2017-06-27 2017-06-27
CIK: 0001690080 0001690080
ISIN: US68236V3024 US68236V3024
CUSIP: 68236V104 68236V104
Beta: 0.45 0.45
Last Dividend: 0.00 0.00
Dcf Diff: 7.54 7.54
Dcf: 1.73 1.73
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
3
CEO Morning Brief
Emirates Blasts Boeing for Delays, Plans ‘serious Conversations’
4
CEO Morning Brief
Nvidia Rides Fierce Blackwell Demand Towards Stock Record Again
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
